Published in J Nucl Med on December 01, 1982
Evaluation of 18F-2-deoxy-2-fluoro-D-glucose positron emission tomography for gastric cancer. World J Surg (2004) 1.87
Diagnosis of pancreatic cancer by 2[18F]-fluoro-2-deoxy-D-glucose positron emission tomography. Gut (1995) 1.23
Imaging atherosclerosis with hybrid [18F]fluorodeoxyglucose positron emission tomography/computed tomography imaging: what Leonardo da Vinci could not see. J Nucl Cardiol (2012) 0.84
Expression of GLUT-1 and GLUT-3 in xanthogranulomatous cholecystitis induced a positive result on ¹⁸F-FDG PET: report of a case. Int Surg (2013) 0.79
Immunohistochemical expression of glucose transporter 1 in keratin-producing odontogenic cysts. BMC Oral Health (2016) 0.75
On the potential for RF heating in MRI to affect metabolic rates and (18) FDG signal in PET/MR: simulations of long-duration, maximum normal mode heating. Med Phys (2017) 0.75
Distribution volume ratios without blood sampling from graphical analysis of PET data. J Cereb Blood Flow Metab (1996) 9.49
Brain dopamine and obesity. Lancet (2001) 8.00
Graphical analysis of reversible radioligand binding from time-activity measurements applied to [N-11C-methyl]-(-)-cocaine PET studies in human subjects. J Cereb Blood Flow Metab (1990) 6.62
Addiction, a disease of compulsion and drive: involvement of the orbitofrontal cortex. Cereb Cortex (2000) 4.61
Low level of brain dopamine D2 receptors in methamphetamine abusers: association with metabolism in the orbitofrontal cortex. Am J Psychiatry (2001) 4.37
Association of dopamine transporter reduction with psychomotor impairment in methamphetamine abusers. Am J Psychiatry (2001) 4.13
Decreased dopamine D2 receptor availability is associated with reduced frontal metabolism in cocaine abusers. Synapse (1993) 4.13
The relationship of the spleen to the formation of the blood corpuscles. J Physiol (1902) 3.98
Dopamine in drug abuse and addiction: results from imaging studies and treatment implications. Mol Psychiatry (2004) 3.80
Decreased striatal dopaminergic responsiveness in detoxified cocaine-dependent subjects. Nature (1997) 3.76
Tumor marker utility grading system: a framework to evaluate clinical utility of tumor markers. J Natl Cancer Inst (1996) 3.53
Loss of dopamine transporters in methamphetamine abusers recovers with protracted abstinence. J Neurosci (2001) 3.46
Inhibition of granulocyte adherence by ethanol, prednisone, and aspirin, measured with an assay system. N Engl J Med (1974) 3.39
Imaging dopamine's role in drug abuse and addiction. Neuropharmacology (2008) 3.28
Evaluation of positive blood cultures. Guidelines for early differentiation of contaminated from valid positive cultures. Arch Intern Med (1972) 3.26
Association between decline in brain dopamine activity with age and cognitive and motor impairment in healthy individuals. Am J Psychiatry (1998) 3.02
Relationship between subjective effects of cocaine and dopamine transporter occupancy. Nature (1997) 2.94
Changes in brain glucose metabolism in cocaine dependence and withdrawal. Am J Psychiatry (1991) 2.89
Ultra-high resolution SPECT system using four pinhole collimators for small animal studies. J Nucl Med (1995) 2.87
Impaired interleukin 12 production in human immunodeficiency virus-infected patients. J Exp Med (1994) 2.82
Inhibition of monoamine oxidase B in the brains of smokers. Nature (1996) 2.62
Experience with a new technic of intestinal bypass in the treatment of morbid obesity. Ann Surg (1971) 2.50
Dopamine transporter occupancies in the human brain induced by therapeutic doses of oral methylphenidate. Am J Psychiatry (1998) 2.50
Prediction of reinforcing responses to psychostimulants in humans by brain dopamine D2 receptor levels. Am J Psychiatry (1999) 2.49
Therapeutic doses of oral methylphenidate significantly increase extracellular dopamine in the human brain. J Neurosci (2001) 2.41
The [18F]fluorodeoxyglucose method for the measurement of local cerebral glucose utilization in man. Circ Res (1979) 2.41
MIRD pamphlet no. 16: Techniques for quantitative radiopharmaceutical biodistribution data acquisition and analysis for use in human radiation dose estimates. J Nucl Med (1999) 2.41
Regional brain metabolic activation during craving elicited by recall of previous drug experiences. Life Sci (1999) 2.35
Bactericidal antibody after colonization with Neisseria meningitidis. J Infect Dis (1973) 2.35
Sentinel lymph node biopsy in breast cancer: initial experience at Memorial Sloan-Kettering Cancer Center. J Am Coll Surg (1998) 2.32
Phase I and imaging trial of indium 111-labeled anti-epidermal growth factor receptor monoclonal antibody 225 in patients with squamous cell lung carcinoma. J Natl Cancer Inst (1991) 2.19
Urine bacterial counts after sexual intercourse. N Engl J Med (1978) 2.18
Long-term frontal brain metabolic changes in cocaine abusers. Synapse (1992) 2.16
Concentration and occupancy of dopamine transporters in cocaine abusers with [11C]cocaine and PET. Synapse (1997) 2.15
Significance of fill-in after thallium-201 reinjection following delayed imaging: comparison with regional wall motion and angiographic findings. J Nucl Med (1990) 2.15
Copper-62-ATSM: a new hypoxia imaging agent with high membrane permeability and low redox potential. J Nucl Med (1997) 2.14
Reinforcing effects of psychostimulants in humans are associated with increases in brain dopamine and occupancy of D(2) receptors. J Pharmacol Exp Ther (1999) 2.11
Decreases in dopamine receptors but not in dopamine transporters in alcoholics. Alcohol Clin Exp Res (1996) 2.09
Altered glucose metabolism in microvessels from patients with Alzheimer's disease. Ann Neurol (1989) 2.08
Metabolic trapping as a principle of oradiopharmaceutical design: some factors resposible for the biodistribution of [18F] 2-deoxy-2-fluoro-D-glucose. J Nucl Med (1978) 2.07
Considerations in use of jejunoileal bypass in patients with morbid obesity. Ann Surg (1973) 2.04
Intradermal radiocolloid and intraparenchymal blue dye injection optimize sentinel node identification in breast cancer patients. Ann Surg Oncol (1999) 2.02
A fluorinated glucose analog, 2-fluoro-2-deoxy-D-glucose (F-18): nontoxic tracer for rapid tumor detection. J Nucl Med (1980) 2.01
Is methylphenidate like cocaine? Studies on their pharmacokinetics and distribution in the human brain. Arch Gen Psychiatry (1995) 2.00
Serum Vpr regulates productive infection and latency of human immunodeficiency virus type 1. Proc Natl Acad Sci U S A (1994) 2.00
Glucose utilization of cerebral gliomas measured by [18F] fluorodeoxyglucose and positron emission tomography. Neurology (1982) 1.99
Multiple-dose pharmacokinetics of imipenem-cilastatin. Antimicrob Agents Chemother (1984) 1.98
Glucose metabolic rate kinetic model parameter determination in humans: the lumped constants and rate constants for [18F]fluorodeoxyglucose and [11C]deoxyglucose. J Cereb Blood Flow Metab (1985) 1.96
Role of dopamine in drug reinforcement and addiction in humans: results from imaging studies. Behav Pharmacol (2002) 1.95
Altered cerebral energy metabolism in Alzheimer's disease: a PET study. J Nucl Med (1994) 1.90
Food and drug reward: overlapping circuits in human obesity and addiction. Curr Top Behav Neurosci (2012) 1.90
[18F]-2-fluoro-2-deoxy-D-glucose positron emission tomography localizes residual thyroid cancer in patients with negative diagnostic (131)I whole body scans and elevated serum thyroglobulin levels. J Clin Endocrinol Metab (1999) 1.90
Virus infection of endothelial cells. J Infect Dis (1981) 1.87
The case for and technique of heterotopic liver grafting. Transplant Proc (1979) 1.87
Functional evaluation following microvascular oromandibular reconstruction of the oral cancer patient: a comparative study of reconstructed and nonreconstructed patients. Laryngoscope (1991) 1.85
Association between age-related decline in brain dopamine activity and impairment in frontal and cingulate metabolism. Am J Psychiatry (2000) 1.85
Surgical debulking and intraperitoneal chemotherapy for established peritoneal metastases from colon and appendix cancer. Ann Surg Oncol (2001) 1.83
Cancer mortality following treatment for adult hyperthyroidism. Cooperative Thyrotoxicosis Therapy Follow-up Study Group. JAMA (1998) 1.82
Association of methylphenidate-induced craving with changes in right striato-orbitofrontal metabolism in cocaine abusers: implications in addiction. Am J Psychiatry (1999) 1.81
Is [1-11C]putrescine useful as a brain tumor marker? J Nucl Med (1992) 1.80
A strategy for removing the bias in the graphical analysis method. J Cereb Blood Flow Metab (2001) 1.79
Imaging studies on the role of dopamine in cocaine reinforcement and addiction in humans. J Psychopharmacol (1999) 1.78
Brain monoamine oxidase A inhibition in cigarette smokers. Proc Natl Acad Sci U S A (1996) 1.78
Attention to emotion modulates fMRI activity in human right superior temporal sulcus. Brain Res Cogn Brain Res (2001) 1.76
Effects of hyperglycemia on FDG uptake in human brain and glioma. J Nucl Med (1994) 1.74
Changes in body composition after jejunoileal bypass in morbidity obese patients. Am J Surg (1972) 1.71
Imaging endogenous dopamine competition with [11C]raclopride in the human brain. Synapse (1994) 1.68
Lessons learned from 500 cases of lymphatic mapping for breast cancer. Ann Surg (1999) 1.67
Effects of chronic cocaine abuse on postsynaptic dopamine receptors. Am J Psychiatry (1990) 1.66
Estimation of coronary flow reserve with the use of dynamic planar and SPECT images of Tc-99m tetrofosmin. J Nucl Cardiol (2001) 1.63
Flucytosine and amphotericin B: hemodialysis effects on the plasma concentration and clearance. Studies in man. Ann Intern Med (1974) 1.63
Carbon-11-cocaine binding compared at subpharmacological and pharmacological doses: a PET study. J Nucl Med (1995) 1.62
Prophylaxis with weekly versus daily fluconazole for fungal infections in patients with AIDS. Clin Infect Dis (1998) 1.61
Prediction of reversible ischemia after revascularization. Perfusion and metabolic studies with positron emission tomography. Circulation (1995) 1.60
Comparative adherence of granulocytes to endothelial monolayers and nylon fiber. J Clin Invest (1978) 1.60
111Indium-diethylenetriamine pentaacetic acid cerebrospinal fluid flow studies predict distribution of intrathecally administered chemotherapy and outcome in patients with leptomeningeal metastases. Neurology (1998) 1.59
Vaccination of seronegative volunteers with a human immunodeficiency virus type 1 env/rev DNA vaccine induces antigen-specific proliferation and lymphocyte production of beta-chemokines. J Infect Dis (2000) 1.59
Multiply high-level-aminoglycoside-resistant enterococci isolated from patients in a university hospital. J Clin Microbiol (1988) 1.58
Esthesioneuroblastoma: surgical treatment without radiation. Laryngoscope (1990) 1.57
Mechanism of action of methylphenidate: insights from PET imaging studies. J Atten Disord (2002) 1.57
Addiction changes orbitofrontal gyrus function: involvement in response inhibition. Neuroreport (2001) 1.55
The effect of acute severe illness on CD4+ lymphocyte counts in nonimmunocompromised patients. Arch Intern Med (2000) 1.55